Image 2_UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma.tif

Image 2_UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma.tif

Background<p>Lung adenocarcinoma (LUAD) represents a significant global health burden. The absence of reliable biomarkers and the heterogeneity in treatment responses continue to hinder improvements in patient prognosis. This study aimed to identify novel biomarkers capable of predicting patie...

Full description

Saved in:
Bibliographic Details
Main Author: Haofeng Yin (19931343) (author)
Other Authors: Yibo Xue (14331219) (author), Chen Wang (88408) (author), Yanqin Wu (3551333) (author), Yuchen Guo (567559) (author), Chunzhen Li (14835418) (author), Yunyan Zhang (1269093) (author), Shulei Yin (14835424) (author), Tiejun Zhao (230582) (author)
Published: 2025
Subjects:
Genetic Immunology
lung adenocarcinoma
UBE2N
prognosis
biomarker
immunotherapy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items